BofA Lowers its Price Target on Pfizer (PFE) to $26 from $27

On April 1, 2026, a Belgian tribunal ordered Poland and Romania to judge and wage for EUR 1.9B worthy of Covid-19 vaccines from Pfizer, rejecting arguments for non-compliance with a European Commission proviso contract. Poland is required to instrumentality EUR 1.3B worthy of doses and Romania EUR 600M aft some had refused transportation citing pandemic developments and different concerns.

On March 24, 2026, Guggenheim raised its terms people connected Pfizer to $36 from $35 and maintained a Buy rating, citing upcoming Phase 3 information for mevrometostat expected successful the 2nd fractional of 2026 and noting imaginable upside versus downside scenarios tied to the proceedings outcome.

Photo by National Cancer Institute connected Unsplash

On March 23, 2026, Pfizer and Valneva reported Phase 3 VALOR proceedings results for their Lyme illness vaccine candidate, showing efficacy of 73.2% and 74.8% successful 2 analyses, portion noting the archetypal pre-specified statistical criterion was not met owed to less cases, but indicating plans for regulatory submissions.

Pfizer Inc. (NYSE:PFE) develops and commercializes biopharmaceutical products globally.

While we admit the imaginable of PFE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.